BIOMAT Database Logo BIOMAT Database Logo

A promising vaccine candidate against COVID-19. 2020

Xiwei Wang, and Wenwei Tu
Laboratory for Medical Translational Immunology, Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, SAR China.

UI MeSH Term Description Entries

Related Publications

Xiwei Wang, and Wenwei Tu
Spike D614G - A Candidate Vaccine Antigen Against Covid-19.
June 2021, The New England journal of medicine,
Xiwei Wang, and Wenwei Tu
DnaJ, a promising vaccine candidate against Ureaplasma urealyticum infection.
November 2022, Applied microbiology and biotechnology,
Xiwei Wang, and Wenwei Tu
Budesonide: A promising candidate therapeutic for early COVID-19.
August 2021, Annals of medicine and surgery (2012),
Xiwei Wang, and Wenwei Tu
Neopterin: A Promising Candidate Biomarker for Severe COVID-19.
January 2021, Journal of inflammation research,
Xiwei Wang, and Wenwei Tu
Promising Immunotherapies against COVID-19.
August 2021, Advanced therapeutics,
Xiwei Wang, and Wenwei Tu
The Sputnik V Vaccine against COVID-19: A Promising Platform for Mass Vaccination.
February 2022, The Israel Medical Association journal : IMAJ,
Xiwei Wang, and Wenwei Tu
HIV vaccine update. DNA vaccination: a promising candidate for a vaccine against HIV-1?
January 1996, TB & HIV,
Xiwei Wang, and Wenwei Tu
[Vaccine against COVID-19].
December 2021, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
Xiwei Wang, and Wenwei Tu
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment.
October 2020, Signal transduction and targeted therapy,
Xiwei Wang, and Wenwei Tu
Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms.
August 2021, International immunopharmacology,
Copied contents to your clipboard!